Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Other Operating Expenses: 2015-2025

Historic Other Operating Expenses for AC Immune (ACIU) over the last 7 years, with Sep 2025 value amounting to -$23,751.

  • AC Immune's Other Operating Expenses fell 208.31% to -$23,751 in Q3 2025 from the same period last year, while for Sep 2025 it was -$50,694, marking a year-over-year decrease of 109.30%. This contributed to the annual value of $162,096 for FY2024, which is 90.32% down from last year.
  • Per AC Immune's latest filing, its Other Operating Expenses stood at -$23,751 for Q3 2025, which was down 170.23% from $33,821 recorded in Q2 2025.
  • AC Immune's Other Operating Expenses' 5-year high stood at $214.9 million during Q2 2022, with a 5-year trough of -$2.4 million in Q4 2021.
  • Its 3-year average for Other Operating Expenses is $158,911, with a median of $45,338 in 2024.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 142,954.91% in 2022, then slumped by 208.31% in 2025.
  • AC Immune's Other Operating Expenses (Quarterly) stood at -$2.4 million in 2021, then spiked by 116.96% to $414,171 in 2022, then decreased by 3.37% to $400,211 in 2023, then tumbled by 96.01% to $15,981 in 2024, then crashed by 208.31% to -$23,751 in 2025.
  • Its Other Operating Expenses stands at -$23,751 for Q3 2025, versus $33,821 for Q2 2025 and -$76,745 for Q1 2025.